The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 23, 2026 | Deshpande Milind | Director | Grant(A) | 10K | — | $0 |
| Jun 23, 2026 | Deshpande Milind | Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2026 | Jackson Scott Thomas | Director | Grant(A) | 10K | — | $0 |
| Jun 23, 2026 | Jackson Scott Thomas | Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2026 | Smith Cynthia | Director | Grant(A) | 10K | — | $0 |
| Jun 23, 2026 | Smith Cynthia | Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2026 | Thomas Frank E | Director | Grant(A) | 10K | — | $0 |
| Jun 23, 2026 | Thomas Frank E | Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2026 | Vink Patrick V.J.J. | Director | Grant(A) | 10K | — | $0 |
| Jun 23, 2026 | Vink Patrick V.J.J. | Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2026 | Tregoning Kathleen | Director | Grant(A) | 10K | — | $0 |
| Jun 23, 2026 | Tregoning Kathleen | Director | Grant(A) | 20K | — | $0 |
| Jun 23, 2026 | Pottage John C Jr | Director | Grant(A) | 10K | — | $0 |
| Jun 23, 2026 | Pottage John C Jr | Director | Grant(A) | 20K | — | $0 |
| May 4, 2026 | Rajavelu Esther | See Remarks | Sell(S) | 25K | $2.51 | $63K |
| Feb 6, 2026 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 19K | $2.36 | $44K |
| Feb 6, 2026 | Rajavelu Esther | See Remarks | Sell(S) | 37K | $2.36 | $88K |
| Feb 6, 2026 | Rajavelu Esther | See Remarks | Sell(S) | 51K | $2.36 | $120K |
| Feb 4, 2026 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 3K | $2.24 | $8K |
| Feb 3, 2026 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 24K | $2.14 | $52K |
| Feb 2, 2026 | Rajavelu Esther | See Remarks | Sell(S) | 18K | $2.20 | $41K |
| Feb 2, 2026 | Rajavelu Esther | See Remarks | Grant(A) | 249K | — | $0 |
| Feb 2, 2026 | Rajavelu Esther | See Remarks | Grant(A) | 498K | — | $0 |
| Feb 2, 2026 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 19K | $2.20 | $42K |
| Feb 2, 2026 | Keutzer Timothy | Chief Operating Officer | Grant(A) | 68K | — | $0 |
| Feb 2, 2026 | Keutzer Timothy | Chief Operating Officer | Grant(A) | 137K | — | $0 |
| Nov 7, 2025 | Rajavelu Esther | See Remarks | Sell(S) | 40K | $2.37 | $95K |
| Aug 28, 2025 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 2K | $1.97 | $3K |
| Aug 28, 2025 | Mahadevia Ankit | Director | Sell(S) | 7K | $1.97 | $13K |
| Jun 12, 2025 | Tregoning Kathleen | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Thomas Frank E | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Smith Cynthia | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Pottage John C Jr | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Vink Patrick V.J.J. | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Jackson Scott Thomas | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Deshpande Milind | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Mahadevia Ankit | Director | Grant(A) | 20K | — | $0 |
| May 2, 2025 | Rajavelu Esther | See Remarks | Grant(A) | 185K | — | $0 |
| Feb 5, 2025 | Mahadevia Ankit | Director | Sell(S) | 14K | $0.78 | $11K |
| Feb 5, 2025 | Mahadevia Ankit | Director | Sell(S) | 55K | $0.78 | $43K |
| Feb 5, 2025 | Shukla Sath | CEO & President | Sell(S) | 106K | $0.78 | $83K |
| Feb 5, 2025 | Shukla Sath | CEO & President | Sell(S) | 43K | $0.78 | $33K |
| Feb 5, 2025 | Shukla Sath | CEO & President | Sell(S) | 6K | $0.78 | $5K |
| Feb 5, 2025 | Rajavelu Esther | CFO & CBO | Sell(S) | 21K | $0.78 | $16K |
| Feb 5, 2025 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 25K | $0.78 | $19K |
| Feb 5, 2025 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 28K | $0.78 | $22K |
| Feb 5, 2025 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 4K | $0.78 | $3K |
| Feb 3, 2025 | Shukla Sath | CEO & President | Grant(A) | 751K | — | $0 |
| Feb 3, 2025 | Rajavelu Esther | CFO & CBO | Grant(A) | 100K | — | $0 |
| Feb 3, 2025 | Rajavelu Esther | CFO & CBO | Grant(A) | 266K | — | $0 |
| Feb 3, 2025 | Keutzer Timothy | Chief Operating Officer | Grant(A) | 266K | — | $0 |
| Nov 8, 2024 | Rajavelu Esther | CFO & CBO | Sell(S) | 17K | $1.30 | $22K |
| Nov 7, 2024 | Rajavelu Esther | CFO & CBO | Sell(S) | 23K | $1.31 | $31K |
| Aug 27, 2024 | Shukla Sath | CEO & President | Sell(S) | 3K | $1.35 | $4K |
| Aug 27, 2024 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 2K | $1.35 | $3K |
| Aug 27, 2024 | Mahadevia Ankit | Director | Sell(S) | 6K | $1.35 | $8K |
| Aug 5, 2024 | Shukla Sath | CEO and President | Sell(S) | 18K | $1.31 | $23K |
| Aug 2, 2024 | Shukla Sath | CEO and President | Sell(S) | 15K | $1.32 | $20K |
| May 29, 2024 | Pottage John C Jr | Director | Grant(A) | 20K | — | $0 |
| May 29, 2024 | Thomas Frank E | Director | Grant(A) | 20K | — | $0 |
| May 29, 2024 | Smith Cynthia | Director | Grant(A) | 20K | — | $0 |
| May 29, 2024 | Vink Patrick V.J.J. | Director | Grant(A) | 20K | — | $0 |
| May 29, 2024 | Tregoning Kathleen | Director | Grant(A) | 20K | — | $0 |
| May 29, 2024 | Mahadevia Ankit | Director | Grant(A) | 20K | — | $0 |
| May 29, 2024 | Jackson Scott Thomas | Director | Grant(A) | 20K | — | $0 |
| May 29, 2024 | Deshpande Milind | Director | Grant(A) | 20K | — | $0 |
| Feb 5, 2024 | Shukla Sath | CEO and President, Director | Sell(S) | 45K | $1.45 | $65K |
| Feb 2, 2024 | Shukla Sath | CEO and President, Director | Sell(S) | 31K | $1.37 | $42K |
| Feb 2, 2024 | Hamed Kamal | Chief Medical Officer | Sell(S) | 28K | $1.37 | $38K |
| Feb 2, 2024 | Joseph Tamara L | Chief Legal Officer | Sell(S) | 31K | $1.37 | $42K |
| Feb 2, 2024 | Mahadevia Ankit | Director | Sell(S) | 64K | $1.37 | $87K |
| Feb 2, 2024 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 31K | $1.36 | $42K |
| Feb 1, 2024 | Shukla Sath | CEO and President, Director | Grant(A) | 680K | — | $0 |
| Feb 1, 2024 | Rajavelu Esther | See Remarks | Grant(A) | 120K | — | $0 |
| Feb 1, 2024 | Hamed Kamal | Chief Medical Officer | Grant(A) | 240K | — | $0 |
| Feb 1, 2024 | Joseph Tamara L | Chief Legal Officer | Grant(A) | 240K | — | $0 |
| Feb 1, 2024 | Keutzer Timothy | Chief Operating Officer | Grant(A) | 240K | — | $0 |
| Jan 2, 2024 | Tregoning Kathleen | Director | Grant(A) | 36K | $1.12 | $40K |
| Nov 13, 2023 | Rajavelu Esther | See Remarks | Grant(A) | 300K | — | $0 |
| Oct 5, 2023 | Mahadevia Ankit | Director | Grant(A) | 20K | — | $0 |
| Oct 5, 2023 | Jackson Scott Thomas | Director | Grant(A) | 20K | — | $0 |
| Oct 5, 2023 | Vink Patrick V.J.J. | Director | Grant(A) | 20K | — | $0 |
| Oct 5, 2023 | Tregoning Kathleen | Director | Grant(A) | 20K | — | $0 |
| Oct 5, 2023 | Deshpande Milind | Director | Grant(A) | 20K | — | $0 |
| Oct 5, 2023 | Thomas Frank E | Director | Grant(A) | 20K | — | $0 |
| Oct 5, 2023 | Smith Cynthia | Director | Grant(A) | 20K | — | $0 |
| Oct 5, 2023 | Pottage John C Jr | Director | Grant(A) | 20K | — | $0 |
| Sep 13, 2023 | Hamed Kamal | Chief Medical Officer | Sell(S) | 39K | $1.27 | $50K |
| Aug 29, 2023 | Shukla Sath | CEO and President, Director | Sell(S) | 4K | $1.30 | $5K |
| Aug 28, 2023 | Shukla Sath | CEO and President, Director | Sell(S) | 2K | $1.26 | $2K |
| Aug 28, 2023 | Mahadevia Ankit | Director | Sell(S) | 9K | $1.26 | $11K |
| Aug 28, 2023 | Joseph Tamara L | Chief Legal Officer | Sell(S) | 2K | $1.26 | $2K |
| Aug 28, 2023 | Keutzer Timothy | Chief Development Officer | Sell(S) | 2K | $1.26 | $2K |
| Aug 1, 2023 | Shukla Sath | CEO and President, Director | Grant(A) | 266K | — | $0 |
| Jun 12, 2023 | Hamed Kamal | Chief Medical Officer | Grant(A) | 140K | — | $0 |
| Feb 3, 2023 | Mahadevia Ankit | CEO and President, Director | Sell(S) | 12K | $1.81 | $22K |
| Feb 2, 2023 | Shukla Sath | Chief Financial Officer | Sell(S) | 10K | $1.83 | $17K |
| Feb 2, 2023 | Joseph Tamara L | Chief Legal Officer | Sell(S) | 3K | $1.86 | $6K |
| Feb 2, 2023 | Keutzer Timothy | Chief Operating Officer | Sell(S) | 3K | $1.86 | $6K |
| Feb 1, 2023 | Mahadevia Ankit | CEO and President, Director | Grant(A) | 532K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-13. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).